gallium nitrate has been researched along with Neoplasms in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (18.75) | 18.7374 |
| 1990's | 15 (46.88) | 18.2507 |
| 2000's | 8 (25.00) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balogh, S; Csikós, A; Radványi, I | 1 |
| Chitambar, CR | 2 |
| Legrand, SB | 1 |
| McCarthy, AA | 1 |
| Goranov, SE; Simeonov, SB | 1 |
| Leyland-Jones, B | 2 |
| Jakupec, MA; Keppler, BK | 1 |
| Igaz, P; Tulassay, Z | 1 |
| Bockman, RS; Coonley, CJ; Isaacs, M; Staszewski, H; Warrell, RP | 1 |
| Alcock, N; Brown, J; Kelsen, DP; Yeh, S; Young, C | 1 |
| Baker, LH; Fraile, RJ; O'Bryan, R; Samson, MK | 1 |
| Harvey, HA | 1 |
| Pecherstorfer, M; Raue, F | 1 |
| Hall, TG; Schaiff, RA | 1 |
| Ralston, SH | 1 |
| Chisholm, MA; Mulloy, AL; Taylor, AT | 1 |
| Davidson, TG | 1 |
| Hansen, LA; Hughes, TE | 1 |
| Fitton, A; Todd, PA | 1 |
| Vogelzang, NJ | 1 |
| Heller, G; Murphy, WK; O'Dwyer, PJ; Schulman, P; Warrell, RP | 1 |
| Krakoff, IH | 1 |
| Warrell, RP | 1 |
| Bockman, RS; Warrell, RP | 1 |
| Bonjour, JP; Jung, A; Rizzoli, R | 1 |
| Alcock, NW; Bockman, RS; Skelos, A; Warrell, RP | 1 |
21 review(s) available for gallium nitrate and Neoplasms
| Article | Year |
|---|---|
[The significance of early diagnosis of cancer-related hypercalcaemia].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Resorption; Calcium; Denosumab; Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Early Diagnosis; Fluid Therapy; Gallium; Humans; Hypercalcemia; Incidence; Neoplasms; Osteolysis; Palliative Care; Prevalence; RANK Ligand | 2013 |
Gallium and its competing roles with iron in biological systems.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Biological Transport; Drug Evaluation; Drug Screening Assays, Antitumor; Gallium; Gallium Isotopes; Homeostasis; Humans; Iron; Mice; Mitochondria; Neoplasms; Nonheme Iron Proteins; Rats; Transferrin | 2016 |
Modern management of malignant hypercalcemia.
Topics: Bone Density Conservation Agents; Calcitonin; Clinical Protocols; Diphosphonates; Fluid Therapy; Gallium; Humans; Hypercalcemia; Imidazoles; Neoplasms; Palliative Care; Pamidronate; Parathyroid Hormone-Related Protein; Zoledronic Acid | 2011 |
Bone lesions in malignant diseases--II. Therapeutic management.
Topics: Bone Diseases; Calcitonin; Diphosphonates; Gallium; Humans; Hypercalcemia; Neoplasms | 2002 |
Gallium nitrate revisited.
Topics: Antineoplastic Agents; Bone and Bones; Gallium; Humans; Hypercalcemia; Lymphoma; Neoplasms | 2003 |
Treatment of cancer-related hypercalcemia: the role of gallium nitrate.
Topics: Antineoplastic Agents; Gallium; Humans; Hypercalcemia; Neoplasms; Randomized Controlled Trials as Topic | 2003 |
Gallium and other main group metal compounds as antitumor agents.
Topics: Antineoplastic Agents; Gallium; Humans; Hypercalcemia; Inorganic Chemicals; Neoplasms; Organometallic Compounds | 2004 |
Targeting apoptosis and DNA synthesis: understanding treatment concepts and nursing considerations.
Topics: Antineoplastic Agents; Apoptosis; DNA Replication; Gallium; Genes, bcl-2; Humans; Neoplasms; Nucleic Acid Synthesis Inhibitors | 2004 |
[Hypercalcemia in neoplastic and granulomatous diseases: pathogenesis and treatment options].
Topics: Animals; Antineoplastic Agents; Blood Volume; Calcitonin; Diphosphonates; Diuresis; Gallium; Glucocorticoids; Granuloma; Humans; Hypercalcemia; Neoplasms | 2005 |
The management of hypercalcemia of malignancy.
Topics: Bone Diseases, Metabolic; Bone Resorption; Cytokines; Diphosphonates; Gallium; Humans; Hypercalcemia; Neoplasms; Osteoclasts | 1995 |
Drug therapy of hypercalcemia due to malignancy.
Topics: Antineoplastic Agents; Calcitonin; Diphosphonates; Diuretics; Fluid Therapy; Gallium; Glucocorticoids; Humans; Hypercalcemia; Neoplasms; Paraneoplastic Syndromes; Plicamycin | 1994 |
Update on the medical treatment of hypercalcemia of malignancy.
Topics: Animals; Antineoplastic Agents; Calcitonin; Diphosphonates; Etidronic Acid; Gallium; Humans; Hypercalcemia; Neoplasm Proteins; Neoplasms; Neoplasms, Experimental; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Treatment Outcome | 1993 |
Pathogenesis and management of cancer associated hypercalcaemia.
Topics: Antineoplastic Agents; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Diuretics; Etidronic Acid; Fluid Therapy; Gallium; Humans; Hypercalcemia; Neoplasms; Pamidronate; Phosphates; Plicamycin; Research | 1994 |
Acute management of cancer-related hypercalcemia.
Topics: Calcitonin; Diphosphonates; Fluid Therapy; Gallium; Glucocorticoids; Humans; Hypercalcemia; Neoplasms; Plicamycin | 1996 |
Conventional treatment of hypercalcemia of malignancy.
Topics: Calcitonin; Clinical Protocols; Diphosphonates; Drug Costs; Fluid Therapy; Gallium; Humans; Hydrocortisone; Hypercalcemia; Imidazoles; Neoplasms; Nucleic Acid Synthesis Inhibitors; Plicamycin; Prednisone; Rehydration Solutions; Zoledronic Acid | 2001 |
Gallium nitrate.
Topics: Gallium; Humans; Hypercalcemia; Neoplasms | 1992 |
Gallium nitrate. A review of its pharmacological properties and therapeutic potential in cancer related hypercalcaemia.
Topics: Animals; Gallium; Humans; Hypercalcemia; Neoplasms | 1991 |
Nephrotoxicity from chemotherapy: prevention and management.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Gallium; Humans; Ifosfamide; Kidney Diseases; Methotrexate; Mitomycin; Neoplasms; Nitrosourea Compounds; Plicamycin | 1991 |
Pharmacokinetics and therapeutic index of gallium nitrate.
Topics: Antineoplastic Agents; Gallium; Humans; Neoplasms | 1991 |
Gallium in the treatment of hypercalcemia and bone metastasis.
Topics: Animals; Bone Neoplasms; Gallium; Humans; Hypercalcemia; Neoplasms | 1989 |
[Tumoral hypercalcemia: physiopathology and treatment].
Topics: Bone and Bones; Bone Neoplasms; Bone Resorption; Calcitonin; Calcitriol; Calcium; Diphosphonates; Diuretics; Fluid Therapy; Gallium; Glucocorticoids; Humans; Hypercalcemia; Intestinal Absorption; Kidney Tubules; Middle Aged; Neoplasms; Parathyroid Hormone; Phosphates; Plicamycin; Prostaglandin Antagonists | 1985 |
4 trial(s) available for gallium nitrate and Neoplasms
| Article | Year |
|---|---|
Gallium nitrate.
Topics: Gallium; Humans; Hypercalcemia; Neoplasms | 1992 |
A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia.
Topics: Adult; Aged; Analysis of Variance; Calcium; Creatinine; Double-Blind Method; Etidronic Acid; Female; Gallium; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Phosphates; Regression Analysis | 1991 |
Clinical trials of gallium nitrate in patients with cancer-related hypercalcemia.
Topics: Antineoplastic Agents; Calcitonin; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Etidronic Acid; Gallium; Humans; Hypercalcemia; Neoplasms | 1991 |
Study in 25 patients shows gallium nitrate superior therapy for hypercalcemia in cancer patients.
Topics: Antineoplastic Agents; Calcium; Etidronic Acid; Gallium; Humans; Hypercalcemia; Neoplasms | 1990 |
8 other study(ies) available for gallium nitrate and Neoplasms
| Article | Year |
|---|---|
Genta incorporated. Gallium therapeutics: take two.
Topics: Antineoplastic Agents; Chemistry, Pharmaceutical; Clinical Trials, Phase II as Topic; Gallium; Humans; Neoplasms | 2002 |
Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia.
Topics: Animals; Bone Resorption; Calcium; Calcium Radioisotopes; Female; Gallium; Humans; Hypercalcemia; Hypocalcemia; Male; Neoplasms; Pilot Projects; Pregnancy; Rats | 1984 |
Pharmacokinetics of gallium nitrate in man.
Topics: Adolescent; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Gallium; Half-Life; Humans; Infusions, Parenteral; Kinetics; Neoplasms; Tissue Distribution | 1980 |
Phase I-II clinical trial of gallium nitrate (NSC-15200).
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Gallium; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms | 1980 |
Gallium nitrate, "the most potent agent available," approved by FDA for hypercalcemia of cancer.
Topics: Antineoplastic Agents; Gallium; Humans; Hypercalcemia; Neoplasms; United States; United States Food and Drug Administration | 1991 |
Gallium nitrate in the treatment of cancer-related hypercalcemia.
Topics: Gallium; Humans; Hypercalcemia; Neoplasms | 1991 |
Gallium for hypercalcemia of malignancy.
Topics: Combined Modality Therapy; Costs and Cost Analysis; Fluid Therapy; Gallium; Humans; Hypercalcemia; Neoplasms | 1991 |
Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis.
Topics: Adult; Aged; Calcium; Creatinine; Dose-Response Relationship, Drug; Female; Gallium; Humans; Hypercalcemia; Kidney; Kinetics; Male; Middle Aged; Neoplasms; Phosphorus; Time Factors | 1986 |